{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:57:38Z","timestamp":1777625858705,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1124\/jpet.112.192203","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T05:07:54Z","timestamp":1339564074000},"page":"850-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Vidofludimus Inhibits Colonic Interleukin-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action"],"prefix":"10.1016","volume":"342","author":[{"given":"Leo R.","family":"Fitzpatrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Doblhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Ammendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.192203_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00384-006-0229-z","article-title":"Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis","volume":"22","author":"Bai","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1124\/jpet.112.192203_bib2","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/embor.2009.243","article-title":"IKK\/NF-\u03baB and STAT3 pathways: central signaling hubs in inflammation-mediated tumour promotion and metastasis","volume":"10","author":"Bollrath","year":"2009","journal-title":"EMBO Rep"},{"key":"10.1124\/jpet.112.192203_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007890-199907150-00020","article-title":"In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression","volume":"68","author":"Chong","year":"1999","journal-title":"Transplantation"},{"key":"10.1124\/jpet.112.192203_bib4","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1038\/onc.2010.109","article-title":"Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer","volume":"29","author":"Danese","year":"2010","journal-title":"Oncogene"},{"key":"10.1124\/jpet.112.192203_bib5","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4049\/jimmunol.157.5.2174","article-title":"Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance","volume":"157","author":"Elson","year":"1996","journal-title":"J Immunol"},{"key":"10.1124\/jpet.112.192203_bib6","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ibd.21264","article-title":"4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease","volume":"16","author":"Fitzpatrick","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.112.192203_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000323911","article-title":"Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine-kinase-2","volume":"87","author":"Fitzpatrick","year":"2011","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.112.192203_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MPG.0b013e3181cb8f4a","article-title":"A new model of chronic hapten-induced colitis in young rats","volume":"50","author":"Fitzpatrick","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1124\/jpet.112.192203_bib9","doi-asserted-by":"crossref","first-page":"S837","DOI":"10.1016\/S0016-5085(11)63470-7","article-title":"Inhibition of IL-17 release by the novel anti-inflammatory drug vidofludimus involves attenuation of STAT3 and NF-\u03baB signaling pathways in murine splenocytes and hapten-induced colitis","volume":"140","author":"Fitzpatrick","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.112.192203_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1017\/S0007114508930373","article-title":"Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis","volume":"100","author":"Fitzpatrick","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1124\/jpet.112.192203_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/clim.1999.4777","article-title":"Mechanism of action for leflunomide in rheumatoid arthritis","volume":"93","author":"Fox","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1124\/jpet.112.192203_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gut.2003.029587","article-title":"CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis","volume":"54","author":"Gao","year":"2005","journal-title":"Gut"},{"key":"10.1124\/jpet.112.192203_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl 1","key":"10.1124\/jpet.112.192203_bib14","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1873-9946(12)60034-8","article-title":"Vidoludimus induces p53-mediated apoptosis in activated T cells and inhibits IL-17a and IL-17F expression decoupled from lymphocyte proliferation","volume":"6","author":"Hamm","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1124\/jpet.112.192203_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-\u03baB and STAT3\u2013key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res"},{"key":"10.1124\/jpet.112.192203_bib16","doi-asserted-by":"crossref","first-page":"S588","DOI":"10.1016\/S0016-5085(11)62435-9","article-title":"Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the entrance study","volume":"140","author":"Herrlinger","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.112.192203_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10620-007-9953-7","article-title":"Treatment of Crohn's disease with leflunomide as second-line immunosuppression: a phase 1 open-label trial on efficacy, tolerability and safety","volume":"53","author":"Holtmann","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.112.192203_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/0-387-33778-4_15","article-title":"From immunogenic mechanisms to novel therapeutic approaches in inflammatory bowel disease","volume":"579","author":"Holtmann","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/jpet.112.192203_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1084\/jem.20081712","article-title":"Circulating and gut resident human Th17 cells express CD161 and promote intestinal inflammation","volume":"206","author":"Kleinschek","year":"2009","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.112.192203_bib20","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/ibd.20543","article-title":"Effects of glutamine on proinflammatory gene expression and activation of nuclear factor \u03baB and signal transducers and activators of transcription in TNBS-induced colitis","volume":"14","author":"Kretzmann","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/jpet.112.192203_bib21","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.2353\/ajpath.2010.091227","article-title":"4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas) Ipr mice","volume":"176","author":"Kulkarni","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.112.192203_bib22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2165\/00003495-200666090-00002","article-title":"Novel treatment options for inflammatory bowel disease: targeting \u03b14 integrin","volume":"66","author":"Lanzarotto","year":"2006","journal-title":"Drugs"},{"key":"10.1124\/jpet.112.192203_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/34.6.3517148","article-title":"Immunohistochemical identification of proliferating cells in organ culture using bromodeoxyuridine and a monoclonal antibody","volume":"34","author":"Morstyn","year":"1986","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/jpet.112.192203_bib24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0022-3565(24)29641-5","article-title":"An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis","volume":"297","author":"Nakase","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.192203_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004836-200308000-00006","article-title":"Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy","volume":"37","author":"Prajapati","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1124\/jpet.112.192203_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/BF02618044","article-title":"Conditions affecting prolonged maintenance of mouse and rat colon in organ culture","volume":"15","author":"Reiss","year":"1979","journal-title":"In Vitro"},{"key":"10.1124\/jpet.112.192203_bib27","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1172\/JCI119013","article-title":"Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2","volume":"98","author":"Reuter","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.112.192203_bib28","doi-asserted-by":"crossref","first-page":"21682","DOI":"10.1074\/jbc.273.34.21682","article-title":"Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans","volume":"273","author":"R\u00fcckemann","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.192203_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1734-1140(11)70396-6","article-title":"IL-17-expressing cells as a potential therapeutic target for treatment of immunological disorders","volume":"63","author":"Strz\u0119pa","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1124\/jpet.112.192203_bib30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.112.192203_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from \u03b3\u03b4 T cells amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1124\/jpet.112.192203_bib32","first-page":"181","article-title":"Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation","volume":"22","author":"Tanabe","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1124\/jpet.112.192203_bib33","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.191.12.2053","article-title":"Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7)","volume":"191","author":"Wittig","year":"2000","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.112.192203_bib34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/01635580903285072","article-title":"Resveratol and piceatannol inhibit iNOS expression and NF-\u03baB activation in dextran sulfate sodium-induced mouse colitis","volume":"61","author":"Youn","year":"2009","journal-title":"Nutr Cancer"},{"key":"10.1124\/jpet.112.192203_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.MIB.0000218764.06959.91","article-title":"Critical role of IL-17 receptor signaling in acute TNBS-induced colitis","volume":"12","author":"Zhang","year":"2006","journal-title":"Inflamm Bowel Dis"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524183413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524183413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.192203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:12:03Z","timestamp":1739985123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524183413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0022356524183413"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.192203","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vidofludimus Inhibits Colonic Interleukin-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.192203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}